EphA4 activation of c-Abl mediates synaptic loss and LTP blockade caused by amyloid-β oligomers
about
Amyloid-β Receptors: The Good, the Bad, and the Prion ProteinTargeting the Eph System with Peptides and Peptide ConjugatesIdentification and characterization of Nanobodies targeting the EphA4 receptor.Altered distribution of the EphA4 kinase in hippocampal brain tissue of patients with Alzheimer's disease correlates with pathologyToward a unified therapeutics approach targeting putative amyloid-β oligomer receptors.Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease.Development and structural analysis of a nanomolar cyclic peptide antagonist for the EphA4 receptorReactive oxygen species trigger motoneuron death in non-cell-autonomous models of ALS through activation of c-Abl signalingEph receptors and ephrins: therapeutic opportunities.Reversing synapse loss in Alzheimer's disease: Rho-guanosine triphosphatases and insights from other brain disorders.EphA4 is Involved in Sleep Regulation but Not in the Electrophysiological Response to Sleep Deprivation.Modifications of a Nanomolar Cyclic Peptide Antagonist for the EphA4 Receptor To Achieve High Plasma StabilityNear infrared light decreases synaptic vulnerability to amyloid beta oligomers.SORLA attenuates EphA4 signaling and amyloid β-induced neurodegeneration.Amyloid β synaptotoxicity is Wnt-PCP dependent and blocked by fasudil.Reduction of Blood Amyloid-β Oligomers in Alzheimer's Disease Transgenic Mice by c-Abl Kinase Inhibition.Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer's Disease
P2860
Q26771532-956DEB6B-4560-451B-9C87-158C3978C466Q26799461-7076AF32-122D-4F02-8EFC-D2D8502A2778Q33882055-64771CB2-D4B7-4374-9F1F-151B3ED805D6Q34109035-A3FEC186-59A1-4476-B703-F059EA537934Q34281219-6B4B4169-1A5B-4434-96C0-32B350AF8042Q34544243-C1749667-6CFA-432F-9CFE-2A2C147177A8Q34756811-819D674A-555D-4FB1-B9EB-027EDE7097CDQ35701794-57F3E3D4-4D2A-42CA-BC72-FF7AE928A1F3Q38257853-79CFD18A-373C-4950-8115-73AB1BE9B467Q38318392-B57929F7-A3F8-4FE3-8EBD-A70734C98883Q38594487-DDAC375F-D37C-45BF-B15B-368602B39B40Q41063994-2A16EA84-753B-43CB-BF7F-554168742576Q43573798-18441AF8-14CC-458D-9191-8CAA10CE6965Q46167371-1C47C760-7AE1-4155-B9B2-0AD967502709Q47620637-B3DB6066-9B9B-459F-8AD0-F8FC497C3FE7Q48547723-C3FF8619-1283-44FC-9B39-8CC2D4E28C31Q57779647-6FF8E4B2-A375-4FF3-B466-7104FA7B2FB7
P2860
EphA4 activation of c-Abl mediates synaptic loss and LTP blockade caused by amyloid-β oligomers
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
EphA4 activation of c-Abl medi ...... caused by amyloid-β oligomers
@ast
EphA4 activation of c-Abl medi ...... caused by amyloid-β oligomers
@en
type
label
EphA4 activation of c-Abl medi ...... caused by amyloid-β oligomers
@ast
EphA4 activation of c-Abl medi ...... caused by amyloid-β oligomers
@en
prefLabel
EphA4 activation of c-Abl medi ...... caused by amyloid-β oligomers
@ast
EphA4 activation of c-Abl medi ...... caused by amyloid-β oligomers
@en
P2093
P2860
P921
P1433
P1476
EphA4 activation of c-Abl medi ...... caused by amyloid-β oligomers
@en
P2093
Adrian González
Alejandra R Alvarez
Elena B Pasquale
Katherine Araya
Katia Gysling
Lina M Vargas
Lisbell D Estrada
Nancy Leal
Nibaldo C Inestrosa
P2860
P304
P356
10.1371/JOURNAL.PONE.0092309
P407
P577
2014-03-21T00:00:00Z